Clinical experience with crizotinib in patients with advanced ALK-rearranged non-small-cell lung cancer and brain metastases.
Journal of Clinical Oncology.
Times cited: 342
Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.
New England Journal of Medicine.
Times cited: 2150